Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-01-27 @ 4:16 AM
Study NCT ID:
NCT01272557
Status:
UNKNOWN
Last Update Posted:
2014-04-01
First Post:
2011-01-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial
Sponsor:
Organization: